Tedizolid Phosphate: A Potent Oxazolidinone Antibiotic for Bacterial Skin and Skin Structure Infections
Discover the efficacy and application of Tedizolid Phosphate in combating challenging Gram-positive bacterial infections.
Get a Quote & SampleProduct Core Value
Tedizolid Phosphate
Tedizolid Phosphate (CAS 856867-55-5) is a second-generation oxazolidinone antibiotic renowned for its potent activity against a spectrum of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). As a prodrug, it is readily converted to its active form, tedizolid, which effectively inhibits bacterial protein synthesis by targeting the 50S ribosomal subunit. This makes it a crucial agent in the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI).
- Explore the Tedizolid Phosphate efficacy against common and resistant Gram-positive pathogens.
- Understand the detailed Tedizolid Phosphate mechanism of action, focusing on ribosomal protein synthesis inhibition.
- Review the comprehensive results from Tedizolid Phosphate clinical trials, showcasing its non-inferiority to established treatments.
- Learn about the recommended Tedizolid Phosphate dosage and administration routes for both adult and pediatric patients.
Key Advantages
Broad-Spectrum Efficacy
This antibiotic demonstrates significant Tedizolid Phosphate efficacy against a wide range of Gram-positive organisms, including difficult-to-treat strains like MRSA, providing reliable therapeutic options for bacterial infections.
Enhanced Potency
As a second-generation oxazolidinone, Tedizolid Phosphate offers enhanced potency compared to earlier agents, leading to improved outcomes in MRSA treatment innovations.
Convenient Dosing Regimen
The 6-day treatment course for ABSSSI simplifies patient adherence and management, making it a practical choice in various clinical settings.
Key Applications
Treatment of ABSSSI
Tedizolid Phosphate is a primary choice for the treatment of bacterial skin infections, effectively addressing conditions like cellulitis, wound infections, and abscesses caused by susceptible Gram-positive bacteria.
Management of MRSA Infections
Its potent activity makes it invaluable for managing infections caused by methicillin-resistant Staphylococcus aureus (MRSA), a critical concern in modern healthcare.
Alternative to Linezolid
New generation antibiotics like Tedizolid Phosphate offer an alternative with a potentially more favorable side-effect profile for patients requiring oxazolidinone therapy.
Research and Development
Tedizolid Phosphate serves as a vital compound for antibacterial prodrug development and ongoing research into new therapeutic strategies against Gram-positive pathogen control.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).